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ABSTRACT
Large-scale copy number variants (CNVs) have
recently been recognized to play a role in human
genome variation and disease. Approaches for anal-
ysis of CNVs in small samples such as microdis-
sected tissues can be confounded by limited
amounts of material. To facilitate analyses of such
samples, whole genome amplification (WGA) tech-
niques were developed. In this study, we explored
the impact of Phi29 multiple-strand displacement
amplification on detection of CNVs using oligonu-
cleotide arrays. We extracted DNA from fresh
frozen lymph node samples and used this for ampli-
fication and analysis on the Affymetrix Mapping 500k
SNP array platform. We demonstrated that the WGA
procedure introduces hundreds of potentially con-
founding CNV artifacts that can obscure detection
of bona fide variants. Our analysis indicates that
many artifacts are reproducible, and may correlate
with proximity to chromosome ends and GC content.
Pair-wise comparison of amplified products consid-
erably reduced the number of apparent artifacts and
partially restored the ability to detect real CNVs. Our
results suggest WGA material may be appropriate
for copy number analysis when amplified samples
are compared to similarly amplified samples and
that only the CNVs with the greatest significance
values detected by such comparisons are likely to
be representative of the unamplified samples.
INTRODUCTION
Initial analysis of the human genome identiﬁed single
nucleotide polymorphisms (SNPs) as the primary source
of genotypic and phenotypic variation among humans.
However, subsequent studies identiﬁed large-scale copy
number variants (CNV) that apparently impacted millions
of nucleotides (1–6). These large-scale variants included
polymorphic deletions and duplications that are present
in >1% of the population and therefore meet the tradi-
tional deﬁnition of polymorphism (2). As of November
2007, 4878 CNV loci impacting 808Mbp of DNA
sequence have been identiﬁed and these are listed in the
Database for Genomic Variants (http://projects.tcag.ca/
variation/). CNVs are also features of several human
diseases including Alzheimer disease (7), Cri du chat syn-
drome (8), mental retardation (9) and cancer (10,11). As
robust array-based methods for copy number detection
continue to mature, increasing numbers of these variants
are being identiﬁed (2).
Current whole-genome methods to detect CNVs require
relatively large input quantities of DNA that are diﬃcult
or impossible to obtain from rare cell populations such as
biopsies and microdissected tissues. To address this chal-
lenge, whole genome ampliﬁcation (WGA) techniques
were developed that increase the amount of DNA for
analysis. For example, multiple-strand displacement
ampliﬁcation (MDA) using Phi29 DNA polymerase was
used to generate microgram quantities of high molecular
weight DNA (>30kb) from nanograms of high quality
input material (12,13). A recent report described a proto-
col for ampliﬁcation of picogram quantities of DNA from
single cells (14), further expanding the applications for this
technique.
The replication ﬁdelity of WGA techniques have been
investigated (15–20). Estimates of base-pair incorporation
errors resulting from Phi29-mediated ampliﬁcation have
ranged from 2.210
5 (21) to 9.510
6 (16) and the
concordance of genotypes between unampliﬁed and
ampliﬁed samples were reported to be >99.8% (16,19).
Recurrent WGA-induced copy number biases were
observed in previous studies (15–20), and were associated
with sequence repeats and proximity to chromosome ends
(17–20), increased GC content (17,20), and annotated
CNVs (17). Many of these associations were explored
descriptively without statistical analysis and there was
no consensus on the 92 recurrent regions of bias explicitly
deﬁned by three of these studies (16,17,20). A recent study
of 532 samples subjected to WGA and subsequent analysis
using the Aﬀymetrix 10k Mapping array identiﬁed a
median of 438 WGA-induced copy number artifacts in
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ﬁed reference set (15). While there is a consensus that at
least partial compensation of systematic biases can be
achieved through the use of an ampliﬁed reference
(16–20), it is unknown to what degree such comparisons
can capture real CNVs detected using more sensitive,
higher resolution platforms.
Recently, bias induced by a number of whole genome
ampliﬁcation protocols was examined using a high-
throughput, massively parallel whole genome pyrosequen-
cing technique (22). In this comparison, which involved
sequencing two bacterial genomes, Phi29 MDA-based
approaches generated the most complete genome coverage
(50–99%), and introduced the least bias compared to
other PCR-based techniques. DNA sequences generated
from Phi29-ampliﬁed material were 2.9–3.8% lower in
GC-content than those from the unampliﬁed material,
suggesting a relationship between ampliﬁcation bias and
GC-content. However, over-ampliﬁcation of certain
sequences could not be explained by any of the previously
mentioned sources of bias suggesting a need to directly
investigate the nature of regions prone to over- or
under-ampliﬁcation. Although the study was of high
resolution, direct comparison of the results from this
study with those using human samples is diﬃcult due to
diﬀerences in chromosome organization, size and
composition.
In this study, we investigated ampliﬁcation bias result-
ing from whole genome ampliﬁcation on DNA from fresh-
frozen human tissues using the Aﬀymetrix 500k Mapping
Array Set. We quantiﬁed the eﬀects of WGA on micro-
array signal and background noise, localized and statisti-
cally analysed genomic regions of WGA-induced bias, and
directly compared the ability to resolve CNVs in compar-
isons of unampliﬁed and ampliﬁed material.
MATERIALS AND METHODS
Tissue materialand DNA extraction
Normal lymph nodes from three individuals were fresh
frozen in Optimal Cutting Temperature (OCT; Sakura
Finetek, Torrance, CA) compound and stored at 808C
by the service pathology laboratory at the BC Cancer
Agency. Genomic DNA was extracted from these sources
using the Gentra PureGene DNA puriﬁcation kit (Gentra
Systems, Minneapolis, MN). Prior to labelling and micro-
array hybridization, the genomic DNA was quantiﬁed
using a NanoDrop spectrophotometer (NanoDrop
Technologies, Wilmington, DE). Prior to whole genome
ampliﬁcation, the genomic DNA was diluted to 1.5ng/ml
and quantiﬁed using a PicoGreen assay (Invitrogen,
Carlsbad, CA). To ensure consistent DNA quality
across all samples, the DNA was visualized on an agarose
gel to conﬁrm the presence of undegraded, predominantly
high molecular weight (>10kb) DNA.
Whole genome amplification
We used Qiagen’s Repli-G Mini whole genome ampliﬁca-
tion kit and protocol (QIAgen, Valencia, CA) to amplify
7ng of PicoGreen-quantiﬁed DNA from fresh frozen
samples to generate >10mg of high molecular weight
DNA. We performed the isothermal ampliﬁcation reac-
tion in 1.5ml microcentrifuge tubes incubated in a 308C
water bath for 18h and inactivated the enzyme by incu-
bating the tubes in a 658C water bath for 3min. The
ampliﬁed products were puriﬁed and quantiﬁed as
described in the previous section and the ampliﬁcation
products were visualized on a 0.8% agarose gel stained
with SYBR Green (Invitrogen, Carlsbad, CA).
Labelling andhybridization tothe Affymetrix 500k array
500ng samples of DNA were processed following the
instructions in the GeneChip Mapping 500K manual
(Aﬀymetrix, Santa Clara, CA). Brieﬂy, 250ng of DNA
was digested using one of two restriction enzymes, Nsp I
or Sty I, and ligated to Nsp I or Sty I adaptors. These
adaptor-ligated fragments were ampliﬁed by PCR and the
puriﬁed products quantiﬁed using a Bio-Tek PowerWave
X spectrophotometer and the concentration normalized to
2mg/ml. The normalized products were then fragmented
and labelled as described in the manual. Samples were
hybridized to the GeneChip Human Mapping 250K Nsp
or Sty array in an Aﬀymetrix Hybridization Oven 640.
Washing and staining of the arrays were performed
using an Aﬀymetrix Fluidics Station 450. Images of the
arrays were obtained using an Aﬀymetrix GeneChip
Scanner 3000.
Sample preparation forNimbleGen 385kCGH array
Samples of >2.5mg of DNA were prepared following the
instructions provided by NimbleGen Systems Inc.
(NimbleGen Systems Inc, Madison, Wisconsin). Brieﬂy,
puriﬁed samples were concentrated to 250ng/ml and ana-
lysed for quality on an agarose gel. Samples were then
shipped on ice to NimbleGen for subsequent labelling
and hybridization to the 385k Human Whole-Genome
CGH array.
Genotype andcopy number analysis
Genotype calls were derived from microarray images
using the GTYPE v4.0 software program (Aﬀymetrix,
Santa Clara, CA). We detected CNVs in individual sam-
ples using comparisons to a common reference data set
and comparisons between pre- and post-ampliﬁcation
sample pairs (Figure 1). These were performed using a
software pipeline (Figure 1) that utilizes the Aﬀymetrix
Chromosome Copy Number Analysis Tool (CNAT) ver-
sion 4.0 (Aﬀymetrix, Santa Clara, CA) and an exhaustive
t-score optimization algorithm.
To analyse sample pairs on the Aﬀymetrix platform, we
used CNAT to perform quantile normalization of probe
intensities from the samples and calculated log2 intensity
ratios for each probe set on the array. For unpaired
analysis of individual samples against a common reference
set, we used a set of average probe intensities from the
reference set in place of the second sample. The reference
set used for this purpose, referred to hereafter as the
‘Aﬀy48 reference set’, was downloaded from the
Aﬀymetrix website (http://www.aﬀymetrix.com/support/
technical/sample_data/500k_data.aﬀx) and consisted of
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HapMap Yoruban trios, three other non-HapMap trios,
and nine unrelated HapMap Asian samples. To analyse
sample pairs on the NimbleGen platform, we used qspline
normalized data and log2 intensity ratios provided by
NimbleGen for each probe on the array.
To identify signiﬁcant deviations in the log2 ratio data
from both platforms, the following t-score optimization
algorithm was used. First, log2 ratios were sorted by
genome coordinate and moving windows representing a
number of adjacent probes were subjected to a t-test
against the rest of the data outside of the window on the
same chromosome. This was done across the entire
genome for all window sizes from 3 to 30 probe sets for
the Aﬀymetrix and NimbleGen data. To establish a
comparison-speciﬁc false-positive threshold, the order of
log2 ratios was then randomized and moving window
t-tests were recalculated. Two t-score thresholds, one for
ampliﬁcations and one for deletions, were then deﬁned at
which no ampliﬁcations or deletions were identiﬁed in the
randomized data. These thresholds were then applied to
the t-scores derived from the original data and regions
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Figure 1. Experimental design. (A) In this study, we aimed to assess the impact of WGA on the detection of CNVs, to explore copy number biases
induced by this technique, and to assess the use of pair-wise analysis to address such biases. To this end, DNA samples from three fresh frozen
tissues were subject to WGA and analyzed pre- and post-ampliﬁcation on the Aﬀymetrix Mapping 500k SNP array set. For each copy number
analysis, diﬀerent sets of microarray data were compared as shown in panels B-D. Log2 intensity ratios were calculated from the selected data
comparisons using a software pipeline based on CNAT v4.0. These ratios were then screened by an ‘exhaustive search’ algorithm, in which t-scores
were calculated in 3–30 probe windows and statistically signiﬁcant aberrations identiﬁed above array-speciﬁc thresholds deﬁned through permutation.
To detect CNVs impacting more than 30 probes, aberrations found to contain more than 27 probes were subject to a t-score optimization using
larger and larger window sizes until a local maximum t-score was found. The resulting high conﬁdence lists of CNVs were then compared as
appropriate for each analysis. (B) In this set of comparisons against a common reference set, we investigated the eﬀect of WGA on array noise (i.e.,
the distribution of log2 ratios) and the ability to resolve CNVs. To this end, each unampliﬁed and ampliﬁed sample was independently compared
against the Aﬀy48 reference set, log2 ratios calculated and detected CNVs were compared. (C) To assess the nature of bias induced by WGA, this
data set directly compared matched pre- and post-WGA samples. Since matched samples were used, all CNVs detected in this analysis are due to the
ampliﬁcation technique. (D) This set of comparisons examined the ability of pair-wise analysis of ampliﬁed samples to reciprocate CNVs detected in
unampliﬁed samples. Three pair-wise comparisons were conducted using both unampliﬁed and ampliﬁed material and the observed CNVs were
compared.
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To identify apparent variants impacting regions larger
than our largest moving window size, t-scores were opti-
mized for aberrations encompassing more than 27 probe
sets using larger and larger windows until a local maxi-
mum t-score was found. As no CNVs met the false posi-
tive thresholds set for the NimbleGen data, a 50 probe
window was used to detect statistically signiﬁcant CNVs
and a comparison-speciﬁc false positive threshold was not
applied.
Sequenceanalysis of recurrent whole genome
amplification-induced artifacts
In the analysis of recurrent WGA-induced artifacts, several
sets of genomic coordinates were deﬁned based on the
human genome reference sequence Build 36/hg18 (released
March, 2006) downloaded from the NCBI website (http://
www.ncbi.nlm.nih.gov/). To deﬁne a set of regions that
were consistently over- or under-ampliﬁed by the whole
genome ampliﬁcation technique, we analysed apparent
variants arising from our comparison of matched pre-
and post-WGA samples for overlapping genomic coordi-
nates across all three comparisons and deﬁned minimal
overlapping regions (Supplementary Tables 1 and 2).
These minimal overlapping regions were deﬁned as the
smallest region overlapped by a WGA-induced variant in
all three comparisons. To deﬁne a subset of recurrently
under-ampliﬁed chromosome ends, the ﬁrst or last 2.5%
of the reference genome sequence of any chromosome was
recorded if it was impacted by a region consistently under-
ampliﬁed by the WGA technique. To serve as reference sets
representing the remainder of the human genome, random
sets of coordinates were generated with equivalent size dis-
tributions for the regions consistently over- or under-
ampliﬁed by the whole genome ampliﬁcation technique
and for the subset of recurrently biased regions aﬀecting
chromosome ends. In these reference sets, 10 random seg-
ments were generated with sizes corresponding to each
entry in the list of regions aﬀected by WGA-induced bias
(i.e. 1900 ampliﬁcations and 750 deletions). The GC and
repeat content of each entry in the above sets of coordi-
nates were calculated in the following manner. For each
set, the genomic sequence for each coordinate was
downloaded from the Ensembl database (http://www.
ensembl.org). To calculate the GC content of the sequence,
the number of Gs and Cs in the sequence was counted and
that number divided by the total length of the sequence. To
calculate the repeat content of the sequence, the coordi-
nates of the UCSC Genome Browser ‘Simple Repeats’
track generated by Tandem Repeats Finder (23) was
used to identify base pairs belonging to repeat sequences.
The number of these base pairs was then divided by the
total length of the sequence to give the percentage of repeat
sequence in the region. As most of the sets were not nor-
mally distributed in GC or repeat content as found by the
Jarque-Bera test, the two-sample Kolmogorov-Smirnov
test (KS test) was used to test whether these sets diﬀered
in their distribution of these two parameters.
RESULTS
Array noise and CNV insamples pre- and post-WGA
To establish a base line for array noise and CNV detection
prior to ampliﬁcation, each unampliﬁed DNA sample was
compared to the Aﬀy48 reference set (Methods; Figure 1b)
and candidate CNVs were identiﬁed. This comparison
versus the Aﬀy48 set was then repeated using ampliﬁed
samples. As a measure of array noise, we quantiﬁed the
distribution of log2 ratios resulting from these compari-
sons by calculating the mean, standard deviation (SD),
and interquartile range (IQR) (Table 1, Figure 2). As
expected due to normalization by CNAT4, the mean
log2 ratios from both unampliﬁed and ampliﬁed samples
were very close to zero. The SDs and IQRs of log2 ratios
from ampliﬁed samples were nearly twice those of the
unampliﬁed samples suggesting an increase in array
noise using WGA material.
To compare the CNVs detected pre- and post-WGA, we
counted apparent CNVs with p-values more signiﬁcant
than each comparison’s false-positive detection limit
(Table 1, Figure 3). The analysis of unampliﬁed samples
detected 13 candidate CNVs, 11 of which overlapped the
coordinates of genomic variants listed in the Database of
Genomic Variants (http://projects.tcag.ca) (5) (Table 2).
In contrast, the analysis of the ampliﬁed samples identiﬁed
1572 apparent CNVs, an approximately 100-fold increase
Table 1. Distribution of log2 ratios from comparison of unampliﬁed and ampliﬁed samples versus a common reference set of 48 individuals
Sample compared versus Aﬀy48 Mean
a SD
b IQR
c Apparent ampliﬁcations Apparent deletions
Count P< Count P<
Sample 1 - Unampliﬁed 0.0002517 0.3079 0.3428 2 1.9910
8 3 1.6510
9
Ampliﬁed 0.001971 0.3790 0.4793 322 9.7610
7 368 9.3910
9
Sample 2 - Unampliﬁed 0.002710 0.2602 0.3152 2 3.7010
7 2 1.0010
16
Ampliﬁed 0.0001297 0.4188 0.5412 254 8.9110
7 157 8.3310
9
Sample 3 - Unampliﬁed 0.003530 0.2584 0.3176 3 5.4210
10 1 1.0010
16
Ampliﬁed 0.0004284 0.4076 0.5178 295 7.4510
7 176 1.3610
8
aMean value of log2 ratios resulting from each comparison. A site with with equivalent copy number in both samples would return a log2 ratio of 0.
bStandard deviation of log2 ratios resulting from from each comparison. These values are interpreted as a measure of data noise from each
comparison.
cInterquartile range of log2 ratios resulting from from each comparison. These values are interpreted as a measure of data noise from each
comparison.
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Figure 3. Apparent CNVs in unampliﬁed and ampliﬁed samples. The number of variants detected in unampliﬁed and ampliﬁed samples from
comparison against the Aﬀy48 reference set were counted. The ampliﬁed samples appear to contain hundreds of CNVs not seen in the unampliﬁed
samples suggesting that WGA over- and under-represents of speciﬁc regions of the genome.
Figure 2. Boxplots comparing the spread of log2 ratios in unampliﬁed and ampliﬁed samples. The log2 ratios resulting from comparison of each
sample against the Aﬀy48 reference set were plotted using a standard box and whisker plot displaying a ﬁve number summary: maximum value or
Q3+1.5IQR, Q3, mean, Q1, and minimum value or Q11.5IQR. Outliers, deﬁned as values that fall more than 1.5  IQR above Q3 or below
Q1, are displayed as individual data points. Due to normalization as part of the CNAT4 analysis pipeline, the mean log2 ratio from each sample is
close to zero. However, the IQR, as well as the maximum and minimum values, were further from the mean in the ampliﬁed samples relative to the
unampliﬁed samples. The increased spread of data distribution is likely due to increased array noise and the detection of ampliﬁcation biases induced
by WGA.
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deletions versus the unampliﬁed samples (Table 1). These
artifactual CNVs are likely the result of WGA-induced
biases.
To assess experimental variation prior to ampliﬁcation,
each unampliﬁed and ampliﬁed sample was subjected to a
pair-wise comparison against an experimental replicate of
itself (Table 3). The lack of ﬂuctuation in mean, SD and
IQR in the log2 ratios from unampliﬁed replicates suggests
a high degree of reproducibility of the array method used.
Similarly, while still elevated relative to unampliﬁed sam-
ples, there is no major ﬂuctuation in these values between
ampliﬁed replicates further supporting the notion that the
WGA method behaves consistently. However, the values
obtained from unampliﬁed samples versus values obtained
from ampliﬁed samples, using the Aﬀy48 reference set,
showed a substantial decrease in SDs and IQRs. This
indicates that ampliﬁed samples produce diﬀerent signal
intensity distributions than unampliﬁed samples, suggest-
ing that comparison of ampliﬁed to unampliﬁed data sets
is potentially problematic.
CNVs induced bywhole genome amplification
To identify apparent CNVs arising from non-uniform
ampliﬁcation bias in the WGA technique, data from
paired pre- and post-WGA samples were directly com-
pared to each other (Figure 1b). Our analysis identiﬁed
apparent WGA-induced over- and under-ampliﬁcations
in each of the three comparisons of ampliﬁed versus
unampliﬁed material. In sample 1, we detected 502 ampli-
ﬁcations (P-value threshold of detection, P<1.6810
6)
and 580 deletions (P<1.7110
8). In sample 2, we
detected 467 ampliﬁcations (P<1.6810
6) and 202
deletions (P<1.6410
8). In sample 3, we detected 546
ampliﬁcations (P<1.6810
6) and 259 deletions
(P<3.4510
8). Our analysis also revealed a set of 265
recurrent apparent WGA-associated aberrations that
were detected in all three comparisons. This set consisted
of 190 over-ampliﬁcations (Supplementary Table 1) and
75 under-ampliﬁcations (Supplementary Table 2). 39
of these regions overlapped one of the 92 regions of
bias (31 of 62 over-ampliﬁcations, 8 of 30 under-
ampliﬁcations) identiﬁed by three previous studies
(16,17,20). 110 of the regions we identiﬁed overlapped
genomic regions with known CNVs (2) (64 over-ampliﬁca-
tions, 46 under-ampliﬁcations) but there was no correla-
tion between regions susceptible to WGA-associated bias
and known CNVs (P=1.00). In a set of 2650 random
genomic coordinates with the same size distribution as
the WGA-induced artifacts, 36.26% overlapped a known
CNV, a proportion near the 41.51% overlap observed
with the set of WGA-induced biases.
The minimal overlapping regions (see Methods) of
WGA-induced over-ampliﬁcations ranged from 2207bp
to 357399bp with a median size of 58961bp, an IQR
of 66524bp and encompassed 13.6Mbp of the ref-
erence human genome sequence. These recurrently over-
ampliﬁed sites were distributed throughout the genome
and had a statistically signiﬁcant increase in GC content
relative to a set of 1900 random genomic segments with
identical size distribution (P=8.3610
40). These over-
ampliﬁed sites were also enriched for repeat sequences
relative to the set of 1900 random genomic segments
(P=1.7610
6). These results are compatible with the
notion that over-ampliﬁcation by the WGA technique is
related to the GC and repeat content of the underlying
sequence.
Table 2. Apparent ampliﬁcations and deletions detected prior to ampliﬁcation through comparison with a reference set of 48 individuals
Sample compared
versus Aﬀy48
Genome coordinates of
variant (NCBI Build
36/hg18/Mar 2006)
Size (bp) CN within
variant
CN outside
variant
SNP
count
P-value Variation locus
a
Ampliﬁcations
Sample 1 chr7:48424572–48431182 6610 2.88184 2.04848 11 1.9910
8 –
chr14:19381928–19492423 110495 2.93812 2.03610 28 4.8510
13 Locus 2636
Sample 2 chr2:113809804–113849256 39452 2.28770 2.04023 12 3.7010
7 Locus 0397
chr17:41569489–41709662 140173 3.07396 2.03694 41 2.3110
12 Locus 3029
Sample 3 chr9:29695281–29706655 11374 2.19958 2.04042 4 <1.0010
16 –
chr14:19309086–19459561 150475 2.65807 2.03481 25 5.4210
10 Locus 2639
chr15:19163125–20077554 914429 2.66995 2.04165 72 <1.0010
16 Locus 2748
Deletions
Sample 1 chr7:142030227–142210594 180367 1.54593 2.04848 27 1.6110
10 Locus 1656
chr14:21451264–22044096 592832 1.51299 2.03610 161 <1.0010
16 Loci 2644 and 2645
chr22:33661041–33725126 64085 1.75349 2.06794 21 1.6510
9 Locus 3489
Sample 2 chr2:50682535–50865587 183052 1.44974 2.04023 40 <1.0010
16 Locus 0329
chr14:21792331–22040096 247765 1.38419 2.02893 60 <1.0010
16 Locus 2645
Sample 3 chr14:21800768–21932862 132094 1.53811 2.03481 32 <1.0010
16 Locus 2645
aFrom the database of genomic variants (http://projects.tcag.ca/variation/).
Table 3. Distribution of log2 ratios from pair-wise comparison of
experimental replicates of unampliﬁed and ampliﬁed samples
Sample Mean SD IQR
Sample 1 - Unampliﬁed 0.005517 0.2579 0.3223
Ampliﬁed 0.002538 0.2840 0.3544
Sample 2 - Unampliﬁed 0.008175 0.2658 0.3299
Ampliﬁed 0.0003263 0.3264 0.4153
Sample 3 - Unampliﬁed 0.0064235 0.2585 0.3187
Ampliﬁed 0.001687 0.2842 0.3517
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WGA-induced under-ampliﬁcations ranged from 5206bp
to 1.93Mbp with a median size of 75698bp, an IQR of
64619 and encompassed 8.37Mb of the reference human
genome sequence. These regions of under-ampliﬁcation
appeared to fall into two groups: those near chromosome
ends and those distributed throughout the genome.
Comparison of the 54 under-ampliﬁed sites distributed
throughout the genome with a set of 540 random genomic
segments with identical size distribution found no statisti-
cally signiﬁcant diﬀerence in GC content (P=0.0796)
or repeat sequences (P=0.1901). However, the under-
ampliﬁcations were greatly depleted for GC-rich regions
compared to the over-ampliﬁcations (P=1.9310
5)
which supports the notion that WGA ampliﬁcation eﬃ-
ciency is related to the GC content of the underlying
sequence. A plot of GC content versus copy number
shows a trend of increasing ampliﬁcation magnitude (i.e.
increasing copy number) with increasing GC content
(Figure 4).
Of the 39 chromosome ends (see Methods) assayed by
probe sets, 15 contained regions of under-ampliﬁcation
(Table 4). Only three chromosome ends contained over-
ampliﬁcations, suggesting that under-representation of
chromosome ends is a consistent result of whole genome
ampliﬁcation. The set of chromosome end under-
ampliﬁcations impacted 2.547Mbp of the reference
human genome sequence and the GC content was statis-
tically greater than that of a set of 150 random genomic
segments with identical size distribution (P=1.1210
6).
However, there was no statistical diﬀerence in GC content
been the under-ampliﬁed chromosome ends and the 25
appropriately ampliﬁed chromosome ends (P=0.8215).
This suggests that ampliﬁcation bias due to GC content
does not play a role in under-ampliﬁcation of speciﬁc sub-
telomeric regions. Under-ampliﬁed chromosome ends were
enriched for repetitive sequences (see Methods) relative to
both a set of 150 random genomic segments with identical
size distribution (P=1.5210
9) and the 25 assayed
chromosome ends that were not under-ampliﬁed
(P=0.0022) suggesting that increased repeat content of
speciﬁc chromosome ends may result in their under-
ampliﬁcation.
To assess WGA-induced CNV artifacts using a second
array platform, we compared pre- and post-ampliﬁcation
sample pairs in three comparative genome hybridization
(CGH) experiments using the NimbleGen 385k array. The
log2 ratios from these experiments were widely distributed
(average SD=0.378, average IQR=0.457) and while
several thousand CNVs were detected, none were identi-
ﬁed with p-values passing the stringent false positive
thresholds set by our algorithm due to the high level of
noise in this data (P<3.5110
7 for over-ampliﬁcations,
P<3.3010
11 for under-ampliﬁcations). Analysis of
this data using a 50 probe moving window without ﬁlter-
ing for false positives detected 2116 WGA-induced CNVs
(466 over-ampliﬁcations, 1650 under-ampliﬁcations)
of which 141 occurred in all three comparisons (29
over-ampliﬁcations, 112 under-ampliﬁcations). Des-
pite their relatively large size (average=1.06Mb,
median=0.36Mb, SD=4.10Mb), only 28 of these over-
lapped recurrent artifacts detected by the Aﬀymetrix
comparisons (17 of 190 over-ampliﬁcations, 11 of 75
under-ampliﬁcations). This amount of overlap is similar
to that seen with a random set of 2116 random genomic
coordinates with the same size distribution as the CNVs
detected by the NimbleGen platform of which 65 over-
lapped a WGA-induced CNV detected by the Aﬀymetrix
platform. These results suggest that these are artifacts
resulting from the diﬃculty in distinguishing real CNVs
from background noise when co-hybridizing ampliﬁed
and unampliﬁed samples even when a large moving
window of 50 probes is used.
Table 4. Regions of recurrent WGA under-ampliﬁcation within chro-
mosome ends
Genome coordinates
(Build 36/hg18/Mar 2006)
Size
(Mbp)
%G C
content
Mbp from nearest
chromosome end
P-terminal end
chr1:3058506–3129776 0.071 57.113 3.059
chr1:5857077–5871605 0.015 57.168 5.857
chr2:554079–613259 0.059 45.934 0.554
chr2:1841469–1968296 0.127 45.876 1.841
chr5:487981–738504 0.251 56.251 0.488
chr5:2187888–2267721 0.080 49.395 2.188
chr5:2836714–2884070 0.047 41.89 2.837
chr5:3160861–3195828 0.035 46.205 3.161
chr8:791584–850907 0.059 47.539 0.792
chr8:1816651–1946694 0.130 49.183 1.817
chr10:2593122–2624375 0.031 37.102 2.593
chr19:373238–892603 0.519 59.541 0.373
q-terminal end
chr6:170198708–170308225 0.110 51.929 0.592
chr7:158582043–158739710 0.158 45.905 0.082
chr10:134327710–134332916 0.005 49.165 1.042
chr12:130611957–130673802 0.062 51.924 1.676
chr13:112193014–112294946 0.102 42.808 1.848
chr13:113053814–113215730 0.162 50.548 0.927
chr15:99580062–99745948 0.166 47.27 0.593
chr16:87408466–87706274 0.298 59.068 1.121
chr20:60967459–61027216 0.060 49.085 1.409
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Figure 4. Copy number distribution and GC content of WGA-induced
CNVs. The number of variants and percentage GC content were
plotted against copy number magnitude for all of the CNVs detected
by comparisons of each pre- and post-WGA sample pair. There
appears to be a direct relationship between the magnitude of over-
ampliﬁcation and increased GC content.
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comparisons
To assess the use of WGA material in pair-wise compar-
isons, each sample was compared to the other samples
one-by-one and relative diﬀerences in copy number in
the three samples assessed using: (i) unampliﬁed samples
versus unampliﬁed samples, (ii) ampliﬁed samples versus
unampliﬁed samples, and (iii) ampliﬁed samples versus
ampliﬁed samples (Figure 1d). An example of the output
from one such set of comparisons is illustrated in Figure 5.
The unampliﬁed versus unampliﬁed comparisons iden-
tiﬁed 21 apparent diﬀerences in copy number among the
three samples (Tables 5 and 6). These pair-wise compar-
isons identiﬁed 5 of 13 apparent diﬀerences expected from
the individual comparisons of samples to the Aﬀy48 refer-
ence set. Twelve of these apparent diﬀerences, including
the ﬁve diﬀerences expected from comparison with the
Aﬀy48 set, overlap variants listed in the Database of
Genomic Variants (http://projects.tcag.ca). The ampliﬁed
versus unampliﬁed comparisons identiﬁed 3207 apparent
diﬀerences in copy number among the three samples
(Table 5). Only seven of these apparent diﬀerences were
detected by both unampliﬁed/ampliﬁed and ampliﬁed/
unampliﬁed comparisons suggesting that systematic
WGA-induced variants and random WGA-reaction varia-
bility mask real events.
The ampliﬁed versus ampliﬁed comparisons identiﬁed
275 apparent diﬀerences in copy number among the
three samples (Table 5). These ampliﬁed versus ampliﬁed
comparisons identiﬁed 2 of the 12 apparent ampliﬁcations
and 5 of the 9 apparent deletions seen in the unampliﬁed
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Figure 5. Example of how a pair-wise comparison of ampliﬁed material
can partially compensate for WGA-induced bias. Shown is the output
of three copy number analyses conducted using our CNV discovery
software pipeline. Copy number, calculated directly from log2 ratios
of probe intensities, is plotted against genome location using a sliding
window of averaged data points, in this case 60 probes. In this example,
a pair-wise comparison of two unampliﬁed samples, identiﬁed a gain of
copy number (P<1.0010
16) in unampliﬁed sample #1 relative to
unampliﬁed sample #2at a locus documented to be copy number vari-
able in the Database of Genomic Variants. Conducting the same com-
parison after WGA of sample #1 results in hundreds of confounding
CNVs from which the known CNV is indistinguishable. However, con-
ducting this comparison after WGA of both samples restores the ability
to detect this CNV. Artifactual variants do still remain as a result of
random variation in the WGA process, however they do not reach the
level of signiﬁcance of the real event. Therefore, when interpreting
results from comparisons of WGA samples, only the top-most hits
are likely to be representative of the unampliﬁed sample.
Table 5. Apparent copy number diﬀerences identiﬁed by pair-wise comparisons of all possible combinations of unampliﬁed and ampliﬁed samples
Samples compared Apparent ampliﬁcations Apparent deletions Total
apparent
CNVs
CNVs in common
between matched
comparisons
Count P< Count P<
Unampliﬁed sample 1
Unampliﬁed sample 2
4 4.2610
7 3 1.4010
8 7–
Unampliﬁed sample 1
Unampliﬁed sample 3
4 3.8810
8 4 1.0510
13 8–
Unampliﬁed sample 2
Unampliﬁed sample 3
4 1.0910
10 2 3.4410
15 6–
Ampliﬁed sample 1
Unampliﬁed sample 2
369 1.2610
6 367 7.7710
9 736 2
Unampliﬁed sample 1
Ampliﬁed sample 2
69 1.0510
6 358 7.0410
9 427
Ampliﬁed sample 1
Unampliﬁed sample 3
471 1.8110
6 498 1.2810
8 969 1
Unampliﬁed sample 1
Ampliﬁed sample 3
110 1.6010
6 536 1.5310
8 646
Ampliﬁed sample 2
Unampliﬁed sample 3
183 1.0710
6 49 5.6410
8 232 4
Unampliﬁed sample 2
Ampliﬁed sample 3
67 1.2810
6 130 3.3110
8 197
Ampliﬁed sample 1
Ampliﬁed sample 2
21 2.0310
6 49 1.7110
8 70 –
Ampliﬁed sample 1
Ampliﬁed sample 3
18 9.6710
7 82 2.6910
8 100 –
Ampliﬁed sample 2
Ampliﬁed sample 3
44 1.8210
6 61 8.2310
8 105 –
e80 Nucleic Acids Research, 2008, Vol. 36, No. 13 PAGE8 OF12comparisons (Table 6), suggesting that pair-wise compar-
isons of material where both samples have been subjected
to WGA can partially compensate for reproducible WGA-
induced bias (Figure 5). The most signiﬁcant deletion
identiﬁed by each unampliﬁed comparison was recapitu-
lated as the most signiﬁcant deletion identiﬁed by the cor-
responding ampliﬁed comparison (Table 6). This was also
true of the most signiﬁcant ampliﬁcation in two of the
three comparisons (Table 6). The list of variants detected
at lower levels of signiﬁcance than these top scoring events
may still contain real CNVs although it is diﬃcult to iso-
late these from the remaining artifactual events resulting
from random experimental variation without independent
validation of each one.
Validation of WGA pair-wise comparisons for copy
number detection
To determine the extent to which ampliﬁed pair-wise com-
parisons mask known, validated CNVs, DNA from the
blood of three father/child pairs with previously described
CNVs (9) were subjected to WGA and copy number ana-
lysis using the 250k Nsp chip of the Aﬀymetrix 500k set.
The original analysis of unampliﬁed DNA performed
using the Aﬀymetrix Mapping 100k SNP array set (9)
identiﬁed a total of 32 CNVs within the three father/
child pairs of which ﬁve (two ampliﬁcations, three dele-
tions) were validated by conventional cytogenetic analysis
(Table 7).
The ampliﬁed child versus ampliﬁed father comparisons
identiﬁed 63 CNVs in copy number in total within the three
pairs. Analysis of ampliﬁed family pair #8379 identiﬁed
41 copy number diﬀerences (13 relative ampliﬁcations
P<3.4810
6, 28 relative deletions P<8.3810
8),
analysis of ampliﬁed family pair #1280 identiﬁed six copy
number diﬀerences (two relative ampliﬁcations
P<2.1410
6, four relative deletions P<1.0510
8),
and analysis of ampliﬁed family pair #3476 identiﬁed 16
copy number diﬀerences (six relative ampliﬁcations
P<2.0710
6, 10 relative deletions P<6.0910
9).
These copy number diﬀerences were then ranked by
P-value (most signiﬁcant to least) and the coordinates
compared to those of the validated aberrations. The ampli-
ﬁed versus ampliﬁed comparisons identiﬁed four of the ﬁve
CNVs (two ampliﬁcations, two deletions) validated by
FISH (9) and each received the lowest P-value for its com-
parison (Table 7). The single validated CNV that was not
detected by the ampliﬁed comparisons may have been
missed due to a diﬀerence in array coverage at this site.
On the 250k Nsp array, this region was covered by three
probe sets (10683bp/probe set) compared to six probe sets
(5341bp/probe set) on the 100k array. This was also the
smallest feature of the set of validated CNVs (0.03Mb) and
may reﬂect a decrease in detection sensitivity when using
ampliﬁed comparisons. Among the top-ranked variants
(i.e. those with the most signiﬁcant P-values), six variants
were identiﬁed by the 250k WGA experiment that were not
detected by the original experiments. Five of these are cov-
ered by six or fewer probe sets (5743–93 452bp/probe set,
one with no probes) on the 100k array. In addition to the
possibility of an increased false positive rate due to
increased array noise, diﬀerences in each array’s probe
coverage may explain why these regions were only detected
by the experiment using ampliﬁed samples.
Table 6. Copy number variants detected by pair-wise comparisons of unampliﬁed and ampliﬁed sample sets
Sample
comparison
Relative CN
diﬀerence
Detected by pairwise comparison
of unampliﬁed samples
Detected by pairwise comparison
of ampliﬁed samples
Variation
locus
a
Coordinates (Build 36) P Rank Coordinates (Build 36) P Rank
1 versus 2 Increase chr2:50775422–51014967 1.0010
16 1 chr2:50828689–50960764 1.1510
9 1 of 21 0329
b
chr14:19272965–19489991 1.3810
10 2 – 2636
chr3:21942154–21975950 3.9110
7 3– –
chr16:22640088–22688093 4.2610
7 4 – 2893
Decrease chr17:41569489–41708649 1.0010
16 1 chr17:41587072–41709662 1.0010
16 1 of 48 3029
chr9:11936421–11997006 5.0910
11 2 – 1901
chr10:95243220–95304377 1.4010
8 3– –
1 versus 3 Increase chr8:124654695–124656225 1.0010
16 1– –
chr13:43692360–43696382 3.9910
13 2– –
chr18:20691186–20697540 4.8610
13 3– –
chr14:19402695–19502641 3.8810
8 4 – 2636
Decrease chr14:21715523–22040167 1.0010
16 1 chr14:21531617–22057862 1.0010
16 1 of 82 2644/5
chr10:54588936–54590136 1.0010
16 1– –
chr17:76310141–76321112 1.0010
16 1– –
chr15:19876834–20005562 1.0510
13 4 chr15:19877365–20077554 2.1110
10 37 of 82 2748
2 versus 3 Increase chr17:41572099–41708649 1.0010
16 1 chr17:41522422–41647903 8.4710
13 1 of 44 3029
chr15:84684853–84693981 1.0010
16 1 – 2830
chr15:98087203–98095507 1.1110
11 3 – 2860
chr16:77105899–77109454 1.0910
10 4– –
Decrease chr15:18711364–20079140 1.0010
16 1 chr15:19313868–20329239 1.0010
16 1 of 61 2748
chr2:50870615–51020480 3.4410
15 2 chr2:50828689–51018056 1.0010
16 1o f6 1 –
aFrom the database of genomic variants (http://projects.tcag.ca/variation/).
bThis CNV locus is overlapped only by the coordinates expected from comparison versus the Aﬀy48 reference set.
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To compare the ﬁdelity of genotype calls derived from
WGA product to those from corresponding unampliﬁed
samples, data from matched pairs of these sources were
compared. Average genotype call rates (1 SD) were
96.741.14% from the unampliﬁed samples and
93.142.68% from the WGA samples, suggesting a
modest degree of information loss following ampliﬁcation.
Of the SNPs which were unsuccessfully called in the ampli-
ﬁed samples, only 2% were common to all three samples
and only one of these fell within a region of WGA-induced
bias (an over-ampliﬁcation). Genotype concordance was
98.570.53% between calls successfully made from both
ampliﬁed and unampliﬁed samples in each matched pair.
There was very little overlap in the coordinates of SNPs
with non-concordant genotypes and regions of recurrent
WGA-induced bias. Of the non-concordant calls, 58.77%
were called heterozygotes in the unampliﬁed sample and
homozygotes in the ampliﬁed sample (i.e. AB called as AA
or BB) and 0.2% of these were located in regions of WGA-
induced over-ampliﬁcation while none were in regions of
WGA-induced under-ampliﬁcation, 40.66% were called
homozygotes in the unampliﬁed sample and heterozygotes
in the ampliﬁed sample (i.e. AA or BB called as AB) of
which none were located in regions of WGA-induced bias,
and 0.57% were incorrectly called homozygotes (i.e. AA
called as BB or BB called as AA) of which none were
located in regions of WGA-induced bias. Twelve regions
each containing 3–7 SNPs were identiﬁed as displaying loss
of heterozygosity (LOH) in total from the three pre- and
post-ampliﬁcation comparisons. Three of the LOH regions
had an allele-speciﬁc copy number of 3 while the others
had a copy number of 2. These regions impacted a total
of 58 SNPs, 0.01% of all of the SNPs assayed, and none
overlapped a region recurrently over- or under-ampliﬁed
by WGA. These results suggest that increased random
array noise is likely a greater source of genotype non-
concordance than systematic allele-speciﬁc ampliﬁcation
bias or polymerase error.
DISCUSSION
The ability to discover CNVs in unampliﬁed human DNA
using data generated by the Aﬀymetrix Mapping SNP
array platform has been previously demonstrated by our
group and others (1–3,9). However, with small amounts of
DNA, from tumour biopsies for example, ampliﬁcation of
the starting material prior to discovery of CNVs is often
necessary to generate enough material to conduct such
analyses. We aimed to assess the nature of biases that
are introduced by this ampliﬁcation, and to determine
their impact on copy number detection and whether
pair-wise comparisons could compensate for these
biases. For the ﬁrst time, we have used a high resolution
microarray platform to explicitly deﬁne regions suscepti-
ble to WGA-induced bias, statistically assessed the
sequence features underlying these biases, and demon-
strated an ability to correct for these biases and resolve
real CNVs. In this study, three unampliﬁed DNA samples
were used to establish a base line for array noise and CNV
detection. These were compared to the same DNA sam-
ples that were ampliﬁed in duplicate using a WGA tech-
nique. The apparent CNVs we detected by comparing
unampliﬁed samples to the unampliﬁed Aﬀy48 reference
set were likely real events, as the variants were relatively
large, statistically signiﬁcant, and 11 of the 13 CNVs cor-
responded to previously documented genomic variants (5).
While our variant detection approach adjusts its threshold
of signiﬁcance based on the level of noise of each array,
comparisons using ampliﬁed samples still identiﬁed hun-
dreds of apparent CNVs not seen in the unampliﬁed com-
parisons on the Aﬀymetrix array platform. Since these
comparisons were performed against an unampliﬁed refer-
ence, it is likely that these artifactual apparent CNVs were
the result of preferentially amplifying of regions of the
genome and not due to an increased level of array noise.
The data from the NimbleGen platform appeared to have
a high level of noise that aﬀected our ability to detect
WGA-induced CNVs when co-hybridizing unampliﬁed
and ampliﬁed samples. Our results suggest that ampliﬁed
Table 7. Copy number variants detected in MR families by pair-wise comparisons of unampliﬁed and ampliﬁed sample sets (child versus father)
Family
ID[9]
Relative
CN
Validated aberrations detected by pairwise comparison of
unampliﬁed samples [9] (100k array set)
Detected by pairwise comparison of ampliﬁed
samples (250k Nsp array)
Variation
locus
a
diﬀerence Coordinates (Build 36) Mbp Validation Cyto-band Coordinates (Build 36) P Rank
b
8379 Increase chr10:259695–23144645 22.88 karyotyping 10p12.2–p15.3 chr10:1000464–24070263 1.0010
16 1 of 13 many
chr15:19208413–19943075 0.73 karyotyping 15q11.2 chr15:18850150–20335459 1.0010
16 1 of 13 2748
– – – – chr14:21394980–21864733 1.0010
16 1 of 13 many
1280 Increase – – – – chr9:10069844–10104307 5.5410
7 1o f2 –
– – – – chr13:100974064–101034679 2.1410
6 2o f2 –
Decrease chr4:22943293–23102259 0.16 FISH (BAC) 4p15.2 chr4:22828003–23025619 3.6410
10 1 of 4 0794
3476 Increase – – – – chr5:64484426–64535538 1.0010
16 1o f6 –
– – – – chr20:50794691–50801972 1.0010
16 1 of 6 3405
Decrease chr1:83242288–83274337 0.03 FISH (fosmid) 1p31.1 – – – 0104
chr4:82282746–85558739 3.28 FISH (BAC) 4q21.23 chr4:82531241–92371701 1.0010
16 1 of 10 many
– – – – chr22:46869824–46963276 1.0010
16 1o f1 0 –
aFrom the database of genomic variants (http://projects.tcag.ca/variation/).
bRanked by signiﬁcance (P-value). Only variants with the lowest P-value scores are shown.
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uncover WGA-induced artifacts using the NimbleGen
CGH array. However, this should not preclude the com-
parison of similarly ampliﬁed samples on this platform as
we have shown using Aﬀymetrix arrays that the biases are
largely systematic and the noise is reduced substantially
when comparing two ampliﬁed samples.
To explore the nature of this bias, we directly compared
Aﬀymetrix data from pre- and post-ampliﬁcation sample
pairs and observed a set of regions apparently over- or
under-ampliﬁed in all three samples. These regions
impacted a total of 21.97Mb of sequence, consisted of
190 over-ampliﬁcations and 75 under-ampliﬁcations, and
overlapped 39 of 92 regions of WGA-induced bias identi-
ﬁed by other studies (16,17,20). The low amount of over-
lap is perhaps due to diﬀerences in genome coverage by
the arrays used in these studies, particularly as there was
no previous consensus on any region being susceptible to
WGA-induced bias. Results reported are for DNA ampli-
ﬁed using the QIAgen Mini kit and it is conceivable that
DNA ampliﬁed using diﬀerent protocols will exhibit dif-
ferent bias. While the lack of a correlation between regions
of WGA-induced bias and known CNVs is diﬀerent from
a previous observation (17), we have demonstrated that
the degree of overlap of the ampliﬁcation biases we iden-
tiﬁed with known CNVs is only slightly greater than
would be expected by chance. The amount of overlap
observed is likely due to the fact that documented CNVs
are generally large, 165kb on average, and, in total,
impact 27% of the genome.
The diﬀerence in size and size distribution of the
over- and under-ampliﬁcations that we identiﬁed sug-
gests focal over-ampliﬁcation of speciﬁc sequences and
broader under-representation of others. We observed a
direct relationship between ampliﬁcation eﬃciency and
GC-content as over-ampliﬁed regions had a statis-
tically signiﬁcant increase in GC content relative to the
deletions (P=1.9310
5) and the magnitude of over-
ampliﬁcation appeared to scale directly with GC richness
(Figure 4). These results are consistent with the notion
that WGA-induced over-ampliﬁcation bias is related
to the increased binding aﬃnity of GC-rich hexamers rela-
tive to AT rich hexamers and not a shortage of hexamers
corresponding to repetitive regions in the genome. There
is also the possibility that, unlike many polymerases,
Phi29 polymerase is more eﬃcient in synthesizing
GC-rich sequences, thereby resulting in over-ampliﬁcation
of these regions. These eﬀects likely also contribute to
under-ampliﬁcation of GC-poor regions distributed
throughout the genome but not likely the loss of chromo-
some ends. The lack of a relationship between regions of
WGA-induced bias and the presence of known CNVs
suggests that diﬀerent mechanisms account for these
phenomena.
The loss of chromosome ends appears to be a consistent
result of the WGA procedure as 15 of the 39 ends assayed
were under-ampliﬁed in all samples compared to only
three that were over-ampliﬁed. Relative to chromosome
ends that were not aﬀected by bias, the under-ampliﬁed
ends were enriched for repetitive sequences (P=0.0022)
but did not have a statistically signiﬁcant diﬀerence in GC
content (P=0.8215). These results suggest that the source
of ampliﬁcation bias at chromosome ends is diﬀerent from
GC-content-derived biases aﬀecting the rest of the
genome. One possible explanation is the positional eﬀect
of having fewer overlapping ampliﬁcation products at the
ends of linear stands of DNA than in the middle.
However, if this were the case then all chromosome ends
should be similarly under-ampliﬁed which they are not.
Another possible explanation is that the limited quantities
of hexamers corresponding to subtelomeric repeats result
in fewer priming events in these regions. This may account
for the loss of repetitive chromosome ends more fre-
quently than less repetitive ends.
We found that samples subject to Phi29-based WGA
can be used for accurate genotyping, albeit with some
data loss. From the WGA samples, we consistently
observed a decrease in the average number of genotype
calls and a wider range of call rates compared to those
from the unampliﬁed samples. However, of the genotype
calls that were made, over 98% were concordant between
ampliﬁed and unampliﬁed sample pairs. The less than
2% non-concordant calls were 99.43% discrepant hetero-
zygotes (i.e. AB called as AA or BB, AA or BB called
as AB), rather than incorrectly called homozygotes,
and nearly none (<0.12%) were located in regions of
WGA-induced bias. This discrepancy rate is very near
that observed between unampliﬁed replicates on the
Aﬀymetrix 500k array (24). It is likely that the source of
genotype call non-concordance is related to the genotyp-
ing accuracy of the array in the presence of increased noise
due to WGA and not truly genotype changes induced by
WGA through allele-speciﬁc ampliﬁcation or polymerase
error.
Regardless of the source of the systematic biases
induced by WGA, we have shown that pair-wise analysis
of ampliﬁed samples is a viable strategy for CNV detec-
tion, albeit with an appropriate threshold of signiﬁcance
to ﬁlter the number of low-signiﬁcance random artifacts
induced by this technique. While the greater number of
apparent copy number diﬀerences detected using ampliﬁed
samples has the potential to mask real events, we observed
that pair-wise comparisons of such samples can detect real
diﬀerences between samples. On comparing ampliﬁed
samples to ampliﬁed samples, the number of artifactual
copy number diﬀerences is reduced by an order of magni-
tude relative to comparisons of ampliﬁed versus unampli-
ﬁed samples due to the systematic nature of the bias
induced by the technique. Conceivably, the use of a
large, ampliﬁed reference set would be a practical alterna-
tive to pair-wise comparisons for larger batches of ampli-
ﬁed samples requiring a universal reference. Of the
apparent copy number diﬀerences detected by the three
pair-wise comparisons using unampliﬁed material, all of
the top deletions and two of the three top ampliﬁcations
were identiﬁed as the most signiﬁcant by the correspond-
ing comparisons using ampliﬁed material. By applying
this technique to paired child/father samples with
known, validated copy number diﬀerences (9), four of
the ﬁve validated diﬀerences detected by the original
study using unampliﬁed DNA were the most signiﬁcant
in the same comparisons using ampliﬁed DNA. The only
PAGE 11 OF12 Nucleic Acids Research, 2008, Vol. 36, No. 13 e80validated CNV that was missed using WGA material was
due to a diﬀerence in coverage by the array platforms
used. A similar diﬀerence in coverage partially explains
the presence of six high conﬁdence CNVs detected by
the WGA experiments not seen in the original study as
one of these has recently been observed in the unampliﬁed
material using a higher resolution platform. Therefore,
when evaluating the results from ampliﬁed comparisons,
CNVs with the top ranked signiﬁcance are more likely to
be real CNVs in the unampliﬁed sample.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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